Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling

OBJECTIVES: Understanding the preferences of patients with multiple sclerosis (MS) for disease-modifying drugs and involving these patients in clinical decision making can improve the concordance between medical decisions and patient values and may, subsequently, improve adherence to disease-modifyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kremer, Ingrid E. H., Evers, Silvia M. A. A., Jongen, Peter J., van der Weijden, Trudy, van de Kolk, Ilona, Hiligsmann, Mickaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094791/
https://www.ncbi.nlm.nih.gov/pubmed/27812117
http://dx.doi.org/10.1371/journal.pone.0164862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094791/
https://www.ncbi.nlm.nih.gov/pubmed/27812117
http://dx.doi.org/10.1371/journal.pone.0164862

Ejemplares similares